AirSculpt Technologies, Inc. (AIRS) vs Entera Bio Ltd. (ENTX)
A side-by-side comparison of AirSculpt Technologies, Inc. and Entera Bio Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AIRS
AirSculpt Technologies, Inc.
$1.91HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
ENTX
Entera Bio Ltd.
$2.62HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — AIRS vs ENTX
growth of $100 · dividends reinvested · last 5yAIRS -87.4% (-34.0%/yr)ENTX -38.5% (-9.3%/yr)ENTX compounded faster over this window
AIRS ENTX
AIRS vs ENTX: by the numbers
- •AIRS is the larger company ($135M vs $129M market cap).
- •Both run net losses; AIRS's is the smaller (-7.79% vs -27235.71% net margin).
Metrics side by side
Valuation
| Metric | AIRS | ENTX |
|---|---|---|
| P/S ratio | 0.89 | N/A |
| P/B ratio | 1.29 | 17.77 |
| EV / EBITDA | 438.56 | N/A |
| FCF yield | 0.56% | N/A |
Profitability
| Metric | AIRS | ENTX |
|---|---|---|
| Gross margin | 57.63% | 0.00% |
| Operating margin | -7.85% | -27450.00% |
| Net margin | -7.79% | -27235.71% |
| ROE | -11.20% | -234.42% |
| ROIC | -7.01% | -82.87% |
Growth (annualized)
| Metric | AIRS | ENTX |
|---|---|---|
| Revenue CAGR (5Y) | 8.17% | N/A |
| FCF CAGR (5Y) | -52.36% | N/A |
| Total return CAGR (5Y) | N/A | -10.57% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.